412 related articles for article (PubMed ID: 9763484)
1. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.
McCann UD; Wong DF; Yokoi F; Villemagne V; Dannals RF; Ricaurte GA
J Neurosci; 1998 Oct; 18(20):8417-22. PubMed ID: 9763484
[TBL] [Abstract][Full Text] [Related]
2. Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations.
Villemagne V; Yuan J; Wong DF; Dannals RF; Hatzidimitriou G; Mathews WB; Ravert HT; Musachio J; McCann UD; Ricaurte GA
J Neurosci; 1998 Jan; 18(1):419-27. PubMed ID: 9412518
[TBL] [Abstract][Full Text] [Related]
3. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users.
McCann UD; Kuwabara H; Kumar A; Palermo M; Abbey R; Brasic J; Ye W; Alexander M; Dannals RF; Wong DF; Ricaurte GA
Synapse; 2008 Feb; 62(2):91-100. PubMed ID: 17992686
[TBL] [Abstract][Full Text] [Related]
4. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.
Sekine Y; Iyo M; Ouchi Y; Matsunaga T; Tsukada H; Okada H; Yoshikawa E; Futatsubashi M; Takei N; Mori N
Am J Psychiatry; 2001 Aug; 158(8):1206-14. PubMed ID: 11481152
[TBL] [Abstract][Full Text] [Related]
5. Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey.
Melega WP; Lacan G; Desalles AA; Phelps ME
Synapse; 2000 Mar; 35(4):243-9. PubMed ID: 10657033
[TBL] [Abstract][Full Text] [Related]
6. In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428.
Wong DF; Yung B; Dannals RF; Shaya EK; Ravert HT; Chen CA; Chan B; Folio T; Scheffel U; Ricaurte GA
Synapse; 1993 Oct; 15(2):130-42. PubMed ID: 8259524
[TBL] [Abstract][Full Text] [Related]
7. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters.
Fischman AJ; Bonab AA; Babich JW; Palmer EP; Alpert NM; Elmaleh DR; Callahan RJ; Barrow SA; Graham W; Meltzer PC; Hanson RN; Madras BK
Synapse; 1998 Jun; 29(2):128-41. PubMed ID: 9593103
[TBL] [Abstract][Full Text] [Related]
8. Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release.
Volkow ND; Wang GJ; Smith L; Fowler JS; Telang F; Logan J; Tomasi D
Neuroimage; 2015 Nov; 121():20-8. PubMed ID: 26208874
[TBL] [Abstract][Full Text] [Related]
9. Quantification of dopamine transporter density in monkeys by dynamic PET imaging of multiple injections of 11C-CFT.
Morris ED; Babich JW; Alpert NM; Bonab AA; Livni E; Weise S; Hsu H; Christian BT; Madras BK; Fischman AJ
Synapse; 1996 Nov; 24(3):262-72. PubMed ID: 8923667
[TBL] [Abstract][Full Text] [Related]
10. Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain.
Madras BK; Gracz LM; Fahey MA; Elmaleh D; Meltzer PC; Liang AY; Stopa EG; Babich J; Fischman AJ
Synapse; 1998 Jun; 29(2):116-27. PubMed ID: 9593102
[TBL] [Abstract][Full Text] [Related]
11. Effects of stimulant drug use on the dopaminergic system: A systematic review and meta-analysis of in vivo neuroimaging studies.
Proebstl L; Kamp F; Manz K; Krause D; Adorjan K; Pogarell O; Koller G; Soyka M; Falkai P; Kambeitz J
Eur Psychiatry; 2019 Jun; 59():15-24. PubMed ID: 30981746
[TBL] [Abstract][Full Text] [Related]
12. Dizocilpine and reduced body temperature do not prevent methamphetamine-induced neurotoxicity in the vervet monkey: [11C]WIN 35,428 - positron emission tomography studies.
Melega WP; Lacan G; Harvey DC; Huang SC; Phelps ME
Neurosci Lett; 1998 Dec; 258(1):17-20. PubMed ID: 9876041
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease.
Frost JJ; Rosier AJ; Reich SG; Smith JS; Ehlers MD; Snyder SH; Ravert HT; Dannals RF
Ann Neurol; 1993 Sep; 34(3):423-31. PubMed ID: 8363363
[TBL] [Abstract][Full Text] [Related]
14. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.
Booij J; Tissingh G; Boer GJ; Speelman JD; Stoof JC; Janssen AG; Wolters EC; van Royen EA
J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):133-40. PubMed ID: 9048712
[TBL] [Abstract][Full Text] [Related]
15. Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD.
Guttman M; Stewart D; Hussey D; Wilson A; Houle S; Kish S
Neurology; 2001 Jun; 56(11):1559-64. PubMed ID: 11402115
[TBL] [Abstract][Full Text] [Related]
16. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.
Volkow ND; Chang L; Wang GJ; Fowler JS; Leonido-Yee M; Franceschi D; Sedler MJ; Gatley SJ; Hitzemann R; Ding YS; Logan J; Wong C; Miller EN
Am J Psychiatry; 2001 Mar; 158(3):377-82. PubMed ID: 11229977
[TBL] [Abstract][Full Text] [Related]
17. The status of dopamine nerve terminals in Parkinson's disease and essential tremor: a PET study with the tracer [11-C]FE-CIT.
Antonini A; Moresco RM; Gobbo C; De Notaris R; Panzacchi A; Barone P; Calzetti S; Negrotti A; Pezzoli G; Fazio F
Neurol Sci; 2001 Feb; 22(1):47-8. PubMed ID: 11487195
[TBL] [Abstract][Full Text] [Related]
18. Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa.
Poyot T; Condé F; Grégoire MC; Frouin V; Coulon C; Fuseau C; Hinnen F; Dollé F; Hantraye P; Bottlaender M
J Cereb Blood Flow Metab; 2001 Jul; 21(7):782-92. PubMed ID: 11435790
[TBL] [Abstract][Full Text] [Related]
19. Comparison of striatal dopamine transporter levels in chronic heroin-dependent and methamphetamine-dependent subjects.
Yuan J; Liu XD; Han M; Lv RB; Wang YK; Zhang GM; Li Y
Addict Biol; 2017 Jan; 22(1):229-234. PubMed ID: 26040446
[TBL] [Abstract][Full Text] [Related]
20. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms.
Sekine Y; Minabe Y; Ouchi Y; Takei N; Iyo M; Nakamura K; Suzuki K; Tsukada H; Okada H; Yoshikawa E; Futatsubashi M; Mori N
Am J Psychiatry; 2003 Sep; 160(9):1699-701. PubMed ID: 12944350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
